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BRAF Mutations Are Sufficient to Promote
Nevi Formation and Cooperate with p53 in the
Genesis of Melanoma
the p53 and BRAF pathways interact genetically to
produce melanoma.
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Melanoma arises from the malignant transformation of1Howard Hughes Medical Institute
melanocytes, the black-pigmented cells carrying mela-2Stem Cell Program and
nin. Similar to other vertebrates, zebrafish have melano-Division of Hematology/Oncology
cytes which are derived from the neural crest (in zebra-Children’s Hospital and
fish, melanocytes are sometimes also referred to asDana-Farber Cancer Institute
melanophores; see [6, 7] and references therein). DuringHarvard Medical School
development, highly conserved cues regulate pigment300 Longwood Avenue
cell fate including the appropriate expression and func-Boston, Massachusetts 02115
tion of themicrophthalmia-associated transcription fac-3Department of Pathology
tor (MITF) [8]. In zebrafish, the Mitfa gene is expressedBrigham and Women’s Hospital
in a tissue-restricted fashion similar to that of M-MITFHarvard Medical School
duringmousemelanocyte development. In addition,Mitf20 Shattuck Street
is mutated in the mousemicrophthalmiamutant and theBoston, Massachusetts 02115
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Thus, the neural-crest-derived melanocyte differentia-Dana-Farber Cancer Institute
tion program is evolutionarily conserved in the verte-Harvard Medical School
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In an effort to determine the effect of activated BRAFBoston, Massachusetts 02115
on melanocyte development, we utilized the mitfa-tis-
sue-restricted promoter to drive expression of human
BRAF in zebrafish embryos [9, 10]. One-cell stage zebra-
fish embryos were microinjected with mitfa-BRAF orSummary
mitfa-BRAFV600E, the most commonmutation associated
with human nevi and melanoma [4]. Wild-type BRAFMelanoma is the most lethal form of skin cancer, and
did not lead to alterations of pigmentation (n  0/66;the incidence and mortality rates are rapidly rising.
Supplemental Table S1). In contrast, althoughBRAFV600E-Epidemiologically, high numbers of nevi (moles) are
injected zebrafish pigment patterns were not noticeablyassociated with higher risk of melanoma [1]. The ma-
altered in early embryos, focal sites ofmelanocyte prolif-jority of melanomas exhibit activating mutations in the
eration (designated fish [f]-nevi) were clearly evident byserine/threonine kinase BRAF [2–4]. BRAF mutations
8 weeks. Ten percent of fish that had been injected withmay be critical for the initiation of melanoma [5]; how-
activated BRAF as embryos displayed f-nevi as adultsever, the direct role of BRAF in nevi and melanoma
(n 49/487). The number and size of f-nevi varied amonghas not been tested in an animal model. To directly
fish, ranging from discrete clusters to pigmentation thattest the role of activatedBRAF in nevus andmelanoma
covered large areas (some over 40%) of the surface ofdevelopment, we have generated transgenic zebrafish
the fish, including the eye (Figures 1A and 1B). Theexpressing the most common BRAF mutant form
ectopic melanocytic lesions were seen in the wild-type(V600E) under the control of themelanocytemitfa pro-
striped backgrounds (AB and Tubingen backgrounds;moter. Expression of mutant, but not wild-type, BRAF
n 8/115; 6.9%) and in the spotted leopard backgroundled to dramatic patches of ectopicmelanocytes,which
(n  41/372; 11.02%). Visibly, the number and size ofwe have termed fish (f)-nevi. Remarkably, in p53-defi-
the f-nevi were similar in both the wild-type and leopardcient fish, activated BRAF induced formation of mela-
backgrounds. Throughout this study, the zebrafish werenocyte lesions that rapidly developed into invasive
monitored closely over time, and generally those thatmelanomas, which resembled human melanomas and
did not have f-nevi by 4 months of age did not acquirecould be serially transplanted. These data provide
them at a later time point. Our results show that themostdirect evidence that BRAF activation is sufficient for
common human BRAFmutation is capable of inducing af-nevus formation, that BRAF activation is among the
dramatic change in zebrafish pigmentation patterns.primary events in melanoma development, and that
Histological examination of f-nevi revealed variable
numbers of excess heavily pigmented melanocytes,
similar tomelanosis in the Xiphophorus species (Figures*Correspondence: zon@enders.tch.harvard.edu
2A–2G; www.xiphophorus.org). F-nevi melanocytes ap-5Present address: Sir William Dunn School of Pathology, University
of Oxford, South Parks Road, Oxford OX1 3RE, United Kingdom. peared well differentiated, but not dysplastic, and with-
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Figure 1. BRAF V600E Induces F-Nevi in Adult Zebrafish
Single cell embryos from (A) wild-type or (B) leopard genetic backgrounds were injected with BRAFV600E and monitored for ectopic melanocytic
proliferations, or f-nevi (asterisks). Top fish are control siblings with normal pigmentation patterns, whereas bottom fish display ectopic f-nevi.
(C) Stable expression of BRAFV600E from the mitfa promoter (bottom) produces ectopic melanocytes on the dorsal side of the fish, widening
the second most posterior adult stripe, and almost fusing with the narrow top stripe, compared to wild-type fish (top).
out evidence of local tissue invasion. These data indi- extra melanocytes, particularly along the dorsum, and
interfering with the most dorsal stripe patterning. Thecate that although expression of BRAFV600E can cause
the expansion/aggregation of melanocytes, additional width of each stripe was larger than wild-type fish, and
the stripes had irregular borders (Figure 1C). Stable ex-mutations are required for the progression tomelanoma.
Given the importance of activated BRAF in human nevi pressionofmitfa-BRAFV600E in leopard fish alsoproduced
offspring with an overt phenotype of extra melanocytes[5], these mutant BRAF-driven melanocytic prolifera-
tions in zebrafish are likely the biological equivalent of along the dorsal axis (data not shown). The localized
expansion of melanocytes in the formation into f-nevi isa human nevus.
To study the biology of BRAFV600E expression in all more prominent in the mosaic animal, microinjected as
an embryo, than in the stable transgenic animal, poten-melanocytes, we generated stable lines of transgenic
mitfa-BRAFV600E zebrafish. Two transgenic lines pro- tially because of differences in the level of BRAF expres-
sion. Our stable transgenic fish lines show that specificduced offspring that exhibited an overt phenotype of
Figure 2. Histology of F-Nevi
(A) Adult fish were sectioned through the head region at the f-nevus, and the section was stained with (B) hematoxylin and eosin stain (100X).
Note the left eye, which had been marked with an f-nevus, contains an expansion of melanocytes (arrow), in contrast to the right, normal eye.
Asterisks indicate regions of nevus in the epidermis. (C) F-nevi contain clusters of melanocytes, abundant with black pigment. Sections stained
with hematoxylin and eosin at 400X and (D) 1000X. (E) Comparison of the subcellular composition of f-nevi before and (F) after bleaching the
melanin at 200X and (G) 400X. Asterisks indicate elongated, heavily pigmented melanocytes in the periocular region, and arrow indicates the
nests of melanocytes in the epidermis. Black scale bar equals 40 microns.
Zebrafish BRAF Melanoma Model
251
Figure 3. Melanoma in Zebrafish
(A) An AB fish homozygous for p53/ rapidly develops melanoma over a 10 day period at the site of a BRAFV600E-induced f-nevus. F-nevi are
seen on the tail, body, and dorsal fin of an adult fish aged 4 months (asterisks; top). Within two days, local pigmentation patterns change at
the site of the f-nevus on the tail of the same fish (middle), and by 4 days, the site of the tail f-nevus has developed into small tumors (not
shown). By day 10, a large tumor mass on the fish is clearly visible (arrow, bottom). (B) Hematoxylin and eosin stain of the tumor shows
densely cellular, mitotically active melanocytic tumor invading the muscle tissue of the tail at 100X and (D) 400X (the black scale bar is 40
microns). (C) Western blot analysis shows the presence of myc-tagged BRAFV600E specifically within the tumor, whereas normal BRAF and
tubulin is detected in normal embryo extract and human tumors. (E) Schmorl stain to detect melanin (blue) demonstrates the presence of
melanin throughout the cells of the tumor (nuclear fast red counterstain; black scale bar equals 40 microns). (F) Electron micrographs confirm
the presence of melanocytes (elongated cell, center) within the tumor and (G) premelanosomes within the melanocyte (arrow). The melanoma
diagnosis has been confirmed by and melanoma sections included in The Registry of Tumors in Lower Animals (www.pathology-registry.org,
case numbers RTLA 7583–7585).
expression of activatedBRAFV600E inmelanocytes signifi- netic defects would be necessary for the progression to
malignant melanoma. Molecularly, loss of the CDKN2Acantly alters melanocyte growth control and patterning.
locus, in addition to activating mutations in the BRAF
gene, is the most common genetic mutation in mela-BRAF and p53 Pathways Cooperate
in the Development of Melanoma noma [1]. The CDKN2A locus encodes two different tu-
mor suppressor proteins, p16INK4a and p19ARF, that act inWe hypothesized that BRAF activation functions as an
early event in nevus formation and that additional ge- distinct genetic pathways: the Rb and p53 pathways,
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Figure 4. Melanoma Characterization
(A) Adult irradiated recipients develop meta-
staticmelanomavisible through the abdomen
(asterisks; top and middle fish; posterior as-
terisk indicates site of injection) and upon
gross examination after sagittal sectioning
and fixation (bottom fish). Characteristics of
themalignant transplanted tumors include (B)
invasion of the liver (100X) and (C) aneuploidy
and polyploidy, as shown by molecular cyto-
genetic analysis of interphase nuclei. Nuclei
are stainedwith DAPI (blue), and near-centro-
meric probes for linkage groups 2 (red) and
16 (green) can be observed. (D) BRAFV600E-
induced tumors are mitotically active. Invad-
ing melanoma cells were stained with anti-
phospho-histone H3 (brown stain, 200X). (E)
BRAFV600E-induced tumors show dramatic ac-
tivation of ERK. Normal (left) and tumor (right)
tissue within the liver of a transplanted fish
were stained with anti-phospho-ERK (brown
stain, 100X). (F) The normal liver has low anti-
phospho-ERK staining, whereas (G) the tu-
mor nodule within the liver displays high lev-
els of anti-phospho-ERK staining (brown
stain, 400X). Black scale bar equals 40 mi-
crons.
respectively [11–13]. Mutations in p53 are surprisingly f-nevi (n  9/66; 13.6%), and, importantly, almost half
of these animals developedmalignantmelanomaby fourinfrequent in melanomas, although p14ARF mutations or
silencing and MDM2 overexpression have been hypoth- months of age (Figure 3A and Supplemental Table S1;
n  4/66). Histological examination revealed these le-esized to inactivate the p53 pathway during the genesis
of human melanomas [12, 14]. In engineered mouse sions to be pigmented, highly invasive melanomas with
nuclear pleomorphism similar to human melanomasmodels of melanoma, RAS p16INK4a/mice acquire so-
matic p53 pathway lesions, and conversely, RAS (Figures 3B and 3D). We performed the Schmorl histo-
chemical technique for reducing substances such asp19Arf/ mice lose p16INK4a function [12]. To test if p53-
pathway deficiency promotes the formation of mela- melanin, which confirmed the presence of melanin
throughout the cells (Figure 3E). Electron micrographsnoma in transgenic zebrafish expressing activated
BRAF, we injected mitfa-BRAFV600E into zebrafish em- also support themelanoma diagnosis, revealing premel-
anosomes and possibly mature melanosomes within abryosharboring ahomozygousmissensemutation (Met-
214Lys) in exon 7 of the zp53 gene (Berghmans et al., subset of the tumor cells (Figures 3F and 3G). Western
blot analysis of tumor extracts confirmed the expressionsubmitted). A wide variety of human cancers havemuta-
tions in the corresponding residue 246 of human p53, of the myc-tagged BRAFV600E transgene (Figure 3C).
Spontaneous melanomas are exceedingly rare in zebra-including the same Met→Lys mutation [15]. The p53
mutant fish lack the apoptotic response to -irradiation fish (The Registry of Tumors in Lower Animals), and
examination of over 10,000 DMBA-treated zebrafishand develop neural tumors at 8.5 months of age. A sub-
set of mitfa-BRAFV600E-injected p53/ fish developed failed to identify a singlemelanoma (J.F.A., J.L. Shepard,
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H.M. Stern, R.D.M., C. Belair, E.E.P., and L.I.Z., unpub- cells (Figures 4E and 4G). Melanoma cells were con-
firmed to be mitotically active by immunostaining forlished data). In addition, melanomas have only been
observed in one out of over 500 p53/ fish aged 11 phospho-histone H3 (Figure 4D). Although mitotically
active tissue might be expected to be active for ERKmonths (Berghmans et al., submitted). Thus, this zebra-
fish melanoma model provides strong evidence for a signaling and our anti-phospho-Erk staining does not
prove a direct connection between BRAF activation andcooperative genetic interaction between the BRAF and
p53 pathways in melanoma development. ERK phosphorylation, it is striking that almost all the
cells in the tumor stain positively for phospho-ERK. This
observation is consistent with the idea that activatedThe Malignant Nature
BRAF signals through the MAP kinase pathway to pro-of BRAFV600E-p53-Induced Tumors
mote the genesis of melanoma.A characteristic of malignant tumors is their transplant-
The melanomas generated by activated BRAF andability. Melanoma cells were transplanted intraperitone-
p53 deficiency in fish are pigmented and bear a strongally into seven sublethal -irradiated wild-type adult ze-
resemblance to humanmelanomas in terms of histologi-brafish [16]. Recipients of melanoma cells exhibited
cal and biological behaviors. The zebrafish comple-black tissue that was visible at the site of injection within
ments other model genetic systems, such as Xiphopho-2 weeks after injection (asterisks, Figure 4A), and mela-
rusandmouse,which are beingused to studymelanomanoma was apparent throughout the body of the adult
[1, 20, 21]. The advantage of the zebrafish model liesfish by 3 weeks after injection (Figure 4A). Sectioning of
in the facile methods for high-throughput screens forthe injected fish revealed extensivemelanoma at the site
suppression or enhancement of phenotypes [22]. Forof injection and invasionofmultiple organs, including the
example, mutations in the Rb pathway might accelerategut, heart, liver, pancreas, kidney marrow, and possible
BRAF p53/melanoma development in the zebrafish;vascular invasion (Figures 4A and 4B). All seven adults
interestingly, Chin and colleagues have shown that mel-injected with melanoma cells succumbed to disease in
anomas in theRASp53/mice retain p16INK4a and over-contrast to none of those that were injected with saline
express myc to inactivate the Rb pathway [1]. Finally,solution alone. The tumor has now been serially trans-
etiological risk factors such as UV exposure, coupledplanted two more times. In contrast, f-nevi showed nei-
with genetic factors for melanoma, can be explored inther transplantability nor the ability to propagate in culture.
this model system and translated to help investigateIn addition to transplantablility, the vast majority of
and treat the human disease.mammalian melanomas show chromosomal alterations
and genetic instability [17]. To assess the extent, if any,
Conclusionsof genomic instability in zebrafish melanomas, we per-
Within the biological context of a zebrafish melanocyte,formed two-color fluorescence in situ hybridization on
we find transgenic expression of human BRAFV600E isinterphase nuclei obtained from a zebrafish melanoma
sufficient for formation of large ectopic f-nevi that are[18]. The hybridization patterns observed suggested
highly melanoma prone when combined with a p53/that 82% (82/100) of the cells were aneuploid, 7% (7/
background, and histological analysis shows high simi-100) of the cells were polyploid, and only 11% (11/100)
larity between zebrafish and human melanomas. Takenwere normal diploid (Figure 4C). These experiments es-
together, this work establishes a melanoma model intablish the transplantability andgenome instability of the
zebrafish, provides the first zebrafish example of a ge-zebrafish melanomas, revealing the malignant nature of
netic interaction promoting cancer, and demonstratesBRAFV600E-p53-induced tumors.
the pathological relevance of the BRAFV600E mutation in
an animal system.The MAPK Cascade Is Activated
in BRAFV600E-p53-Induced Tumors
Supplemental DataThe RAF family of kinases are downstream targets of
Supplemental Experimental procedures for this article are avail-
RAS and are upstream activators of the mitogen-acti- able online at http://www.current-biology.com/cgi/content/full/15/
vatedprotein kinase (MAPK) cascade [1, 4]. Themutually 3/249/DC1/.
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